QUANTRO Therapeutics is a privately funded research company dedicated to the discovery and development of novel effective therapeutics.
QUANTRO Therapeutics has raised $1.9M in total funding. The most recent round was Grant. The last funding was announced in August 2024.
QUANTRO Therapeutics's investors include The Austrian Research Promotion Agency (FFG).
QUANTRO Therapeutics is headquartered in Vienna, Austria.
QUANTRO Therapeutics is a privately funded research company dedicated to the discovery and development of novel effective therapeutics.
QUANTRO Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"QUANTRO Therapeutics — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/quantro-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). QUANTRO Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/quantro-therapeutics
{{cite web |title=QUANTRO Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/quantro-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated